Phase 2 Study of Seliciclib (R-roscovitine) for Cushing Disease
Cushing Disease
Enrolment: 13 · Results not recorded
Drug
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Cushing Disease
Enrolment: 13 · Results not recorded
Cystic Fibrosis
Enrolment: 49 · Results not recorded
Cushings Disease
Enrolment: 4 · Results not recorded
Advanced Solid Tumors
Enrolment: 103 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Moderate contusive spinal cord injury at T8, 10 g weight dropped 25 mm onto an impounder on the exposed dura
CR8 reduced lesion volume at 4 months (40.8 plus or minus 3.6 per cent of total volume versus 52.4 plus or minus 5.0 per cent in vehicle) and attenuated sustained cell cycle protein, GFAP, Iba-1, OX42 and p22PHOX immunoreactivity. BBB scores improved significantly from week 2 and Combined Behaviour…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.